Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 72.00
-2.00 (-2.70%)
Aug 27, 2026, 1:59 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 5.72 billion as of August 26, 2026. Its market cap has decreased by -55.45% in one year.
Market Cap
5.72B
Enterprise Value
3.21B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
72.00
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 5.72B, a decrease of -54.57%. That is a compound annual growth rate of -30.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 5.72B | -23.27% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.72B |
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.07B |
| ADR Biomedical Holdings | 6.81B |
| CellSource | 6.69B |
| Chiome Bioscience | 6.55B |
| Noile-Immune Biotech | 6.29B |
| PRISM BioLab Co.,LTD | 6.28B |